Skip to main content
SpringerLink
Log in

Celecoxib prevents capecitabine-related hand-foot syndrome

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Zhang RX, Wu XJ, Wan DS, Lu ZH, Kong LH, Pan ZZ, Chen G.Celecoxib can prevent capecitabine-related hand-foot syndrome in stage II and III colorectal cancer patients: result of a single-center, prospective randomized phase III trial. Annals of Oncology: 22 Sep 2011. Available from: URL: http://dx.doi.org/10.1093/annonc/mdr400

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Celecoxib prevents capecitabine-related hand-foot syndrome. React. Wkly. 1373, 5 (2011). https://doi.org/10.2165/00128415-201113730-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201113730-00010

Keywords

Search

Navigation